Tech Company Financing Transactions
Vaccinex Funding Round
On 7/10/2017, Vaccinex received $6 million in funding from private investors.
Transaction Overview
Company Name
Announced On
7/10/2017
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1895 Mt. Hope Ave.
Rochester, NY 14620
USA
Rochester, NY 14620
USA
Phone
Website
Email Address
Overview
Vaccinex, Inc. is a biotechnology company engaged in the discovery and development of human monoclonal antibodies to treat a variety of serious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maurice Zauderer
Chief Operating Officer
Raymond Watkins
Chief Scientific Officer
Ernest Smith
VP - Bus. Development
John Leonard
Browse more venture capital transactions:
Prev: 7/10/2017: Drive Motors venture capital transaction
Next: 7/10/2017: Useful Systems venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document tech company VC transactions. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs